<p>WEDNESDAY, May 2 (<span>HealthDay News</span>) — New investigate has uncovered
how some cox-2 painkillers boost a risk for both <span>heart attacks</span> and
stroke.</p>
<p>The once renouned cox-2 drugs, Vioxx and Bextra, were pulled off the
market in 2004 and 2005, respectively, after investigate showed that both
raised a chances of cardiovascular trouble. Meanwhile, Celebrex, a
painkiller in a same drug category that stays on a market, carries a
“black box” warning alerting patients to intensity heart risks.</p>
<p>Now, a group of scientists from a <span>University of Pennsylvania</span> in
Philadelphia contend that, nonetheless cox-2 inhibitors are unequivocally good at
inhibiting a workings of a cox-2 enzyme — and thereby easing <span>pain</span> —
they also chuck off a <span>cardiovascular system</span>‘s <span>delicate balance</span> by
inhibiting an enzyme that relaxes <s...
0 comments
Post a Comment